Have a specific question about your LBP project? Click below and let’s get started.
Blog
- cGMP Manufacturing
- Citations
- Company Information
- Coronavirus
- COVID-19
- Endotoxins
- GMP LPS
- Immune System
- Listlabs
- Live Biotherapeutic Products
- Live Biotherapeutic Services
- Microbiome
- Products
- Recombinant Proteins
- Research
- Select Agents & Toxins
- Services
- Shipping
- Uncategorized
- Vaccines
Category
April 14, 2014
By: douano@listlabs.com
By: Karen Crawford, Ph.D. President, List Biological Laboratories, Inc. You hear about Clostridium difficile at your doctor’s office and in news articles, but what does it mean and how does it affect the world around us? C. Difficile Statisitcs C. Difficile Mortality Rates: Complications from C. difficile infection (CDI) have become an increasing patient safety concern […]
April 7, 2014
By: dpinkston@listlabs.com
List Biological Laboratories, Inc. (List) actively supports and participates in the BabyBIG® project. What is BabyBIG® ? BabyBIG® (Human Botulism Immune Globulin; BIG-IV) is a public service, not-for-profit orphan drug manufactured and distributed by the California Department of Public Health.It is the only therapy available for infants who are infected with the organism that causes […]
March 18, 2014
By: dpinkston@listlabs.com
Shiga Toxins May be Purchased without Government Approval The CDC has removed Shiga toxins (Stx1 and Stx2) from the list of materials requiring oversight. As a result, Shiga Toxins are no longer classified as select agents and may be purchased without government approval for your research and investigative needs. While Shiga toxins carry fewer restrictions, […]
List Biotherapeutics
9800 Crosspoint BIvd Suite 2011
Indianapolis, IN 46256, USA
Find a distributor near you